Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women
Eu‐Leong Yong, Wei Fun Cheong, Zhongwei Huang, Win Pa Pa Thu, Amaury Cazenave‐Gassiot, Kok Yong Seng, Susan Logan
Topics & Concepts
MedicineIcariinPharmacokineticsPlaceboOsteoprotegerinEpimediumOsteoporosisPharmacologyInternal medicineAdverse effectIngestionBone remodelingOsteoclastEndocrinologyTraditional medicinePathologyReceptorAlternative medicineMedicinal herbsHerbActivator (genetics)Medicinal Plant Pharmacodynamics ResearchBone Metabolism and DiseasesBone health and osteoporosis research